What is a stock summary page? Click here for an overview.
Business Description
Prothena Corp PLC
NAICS : 325412
SIC : 2834
ISIN : IE00B91XRN20
Share Class Description:
PRTA: Ordinary SharesDescription
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 43.47 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.51 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -15.3 | |||||
| 3-Year Book Growth Rate | -3.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -13.82 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.83 | |||||
| 9-Day RSI | 41.64 | |||||
| 14-Day RSI | 42.84 | |||||
| 3-1 Month Momentum % | -1.1 | |||||
| 6-1 Month Momentum % | -30.84 | |||||
| 12-1 Month Momentum % | -41.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.01 | |||||
| Quick Ratio | 10.01 | |||||
| Cash Ratio | 9.72 | |||||
| Days Sales Outstanding | 13.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 | |||||
| Shareholder Yield % | -0.53 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -114.36 | |||||
| Net Margin % | -90.5 | |||||
| FCF Margin % | -111.24 | |||||
| ROE % | -22.93 | |||||
| ROA % | -19.68 | |||||
| ROIC % | -214.81 | |||||
| 3-Year ROIIC % | -593.95 | |||||
| ROC (Joel Greenblatt) % | -1014.51 | |||||
| ROCE % | -26.97 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.45 | |||||
| PB Ratio | 1.47 | |||||
| Price-to-Tangible-Book | 1.47 | |||||
| EV-to-EBIT | -1.53 | |||||
| EV-to-EBITDA | -1.54 | |||||
| EV-to-Revenue | 1.75 | |||||
| EV-to-Forward-Revenue | 3.16 | |||||
| EV-to-FCF | -1.54 | |||||
| Price-to-GF-Value | 0.41 | |||||
| Price-to-Median-PS-Value | 0.01 | |||||
| Price-to-Net-Current-Asset-Value | 1.69 | |||||
| Price-to-Net-Cash | 1.75 | |||||
| Earnings Yield (Greenblatt) % | -65.36 | |||||
| FCF Yield % | -20.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PRTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prothena Corp PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 135.157 | ||
| EPS (TTM) ($) | -2.3 | ||
| Beta | -0.83 | ||
| 3-Year Sharpe Ratio | -0.08 | ||
| 3-Year Sortino Ratio | -0.18 | ||
| Volatility % | 39.31 | ||
| 14-Day RSI | 42.84 | ||
| 14-Day ATR ($) | 0.877804 | ||
| 20-Day SMA ($) | 14.17525 | ||
| 12-1 Month Momentum % | -41.24 | ||
| 52-Week Range ($) | 11.7 - 26.36 | ||
| Shares Outstanding (Mil) | 53.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Prothena Corp PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Prothena Corp PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Prothena Corp PLC Frequently Asked Questions
What is Prothena Corp PLC(PRTA)'s stock price today?
The current price of PRTA is $13.34. The 52 week high of PRTA is $26.36 and 52 week low is $11.70.
When is next earnings date of Prothena Corp PLC(PRTA)?
The next earnings date of Prothena Corp PLC(PRTA) is 2025-05-08 Est..
Does Prothena Corp PLC(PRTA) pay dividends? If so, how much?
Prothena Corp PLC(PRTA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers